Jayawardena Nadishka, Burga Laura N, Poirier John T, Bostina Mihnea
Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
Oncolytic Virother. 2019 Oct 29;8:39-56. doi: 10.2147/OV.S218494. eCollection 2019.
Recent advancements in oncolytic virotherapy commend a special attention to developing new strategies for targeting cancer cells with oncolytic viruses (OVs). Modifications of the viral envelope or coat proteins serve as a logical mean of repurposing viruses for cancer treatment. In this review, we discuss how detailed structural knowledge of the interactions between OVs and their natural receptors provide valuable insights into tumor specificity of some viruses and re-targeting of alternate receptors for broad tumor tropism or improved tumor selectivity.
溶瘤病毒疗法的最新进展值得特别关注开发用溶瘤病毒(OVs)靶向癌细胞的新策略。病毒包膜或衣壳蛋白的修饰是将病毒重新用于癌症治疗的合理手段。在本综述中,我们讨论了关于OVs与其天然受体之间相互作用的详细结构知识如何为某些病毒的肿瘤特异性以及重新靶向替代受体以实现广泛的肿瘤嗜性或提高肿瘤选择性提供有价值的见解。